| Literature DB >> 28423614 |
Minling Liu1, Lixian Li2, Wei Yu1, Jie Chen3, Weibin Xiong1, Shuang Chen1, Li Yu1.
Abstract
BACKGROUND: It has been well recognized that the effects of many prognostic factors could change during long-term follow-up. Although marriage has been proven to be a significant prognostic factor for the survival of colon cancer, whether the effect of marriage is constant with time remain unknown. This study analyzed the impact of marital status on the mortality of colon cancer patients with an extended Cox model that allowed for time-varying effects.Entities:
Keywords: all-cause mortality; colon adenocarcinoma; marriage; surveilance; time-varying effect
Mesh:
Year: 2017 PMID: 28423614 PMCID: PMC5386743 DOI: 10.18632/oncotarget.15378
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Baseline Characteristics of the study cohort according to Marital Status (N = 71,955)
| Characteristic | Married(n=41,126) | Unmarried(n=30,829) | P |
|---|---|---|---|
| Vital status | <0.001 | ||
| alive | 24,828(60.37%) | 14,597(47.35%) | |
| dead for colon cancer | 11,005(26.76%) | 9,749(31.62%) | |
| dead for other causes | 5,293(12.87%) | 6,483(21.03%) | |
| Age | 65.64±12.8 | 70.49±14.5 | <0.001 |
| Race | <0.001 | ||
| white | 33,542(81.56%) | 23,805(77.22%) | |
| Black | 3,625(8.81%) | 4,966(16.11%) | |
| Other | 3,959(9.63%) | 2,058(6.68%) | |
| Sex | <0.001 | ||
| Male | 23,982(58.31%) | 10,485(34.01%) | |
| female | 17,144(41.69%) | 20,344(65.99%) | |
| Tumor site | <0.001 | ||
| left | 17,034(41.42%) | 11,281(36.59%) | |
| right | 23,516(57.18%) | 19,004(61.64%) | |
| large intestine, NOS | 576(1.40%) | 544(1.76%) | |
| Grade | <0.001 | ||
| grade I | 3,911(9.51%) | 2,879(9.34%) | |
| grade II | 29,190(70.98%) | 21,436(69.53%) | |
| grade III | 7,441(18.09%) | 6,058(19.65%) | |
| grade IV | 584(1.42%) | 456(1.48%) | |
| Stage | <0.001 | ||
| stage 0/I | 9,870(24.00%) | 6,432(20.86%) | |
| stage II | 12,357(30.05%) | 10,353(33.58%) | |
| stage III | 12,729(30.95%) | 9,470(30.72%) | |
| stage IV | 6,170(15.00%) | 4,574(14.84%) | |
| Tumor stage | <0.001 | ||
| Tis/T0/Tx | 570(1.39%) | 363(1.18%) | |
| T1 | 5,070(12.33%) | 2,947(9.56%) | |
| T2 | 6,269(15.24%) | 4,364(14.16%) | |
| T3 | 24,103(58.61%) | 18,774(60.90%) | |
| T4 | 5,114(12.43%) | 4,381(14.21%) | |
| Nodal stage | 0.102 | ||
| N0 | 23,200(56.41%) | 17,637(57.21%) | |
| N1 | 10,247(24.92%) | 7,611(24.69%) | |
| N2 | 7,672(18.65%) | 5,573(18.08%) | |
| Nx | 7(0.02%) | 8(0.03%) | |
| Metastatic disease | 0.776 | ||
| M0 | 34,953(85.00%) | 26,252(85.15%) | |
| M1 | 6,170(15.0%) | 4,574(14.84%) | |
| Mx | 3(0.01%) | 3(0.01%) | |
| Lymph node rates | 0.096 | ||
| 0.00≤LNR<0.17 | 30,521(74.21%) | 22,990(74.57%) | |
| 0.17≤LNR<0.41 | 5,668(13.78%) | 4,301(13.95%) | |
| 0.41≤LNR<0.69 | 2,839(6.90%) | 1,987(6.44%) | |
| 0.69≤LNR | 2,098(5.10%) | 1,551(5.03%) |
Abbreviations: NOS, not otherwise specified; LNR, lymph node rates.
Figure 1The Kaplan-Meier curves show that the OS of the married patients is better than that of the unmarried patients (p<0.001)
Univariate and Multivariate analysis for all-cause mortality
| Variable | Cox Proportional Hazard Model | Extended Cox Model | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate Analysis | Multivariate Analysis | ||||||||
| HR(95%CI) | pa | PH test* | HR(95%CI) | pb | PHtest* | BaselineHR(95%CI) | P | Time-VaryingHR(95%CI) | P | |
| age | 1.37(1.36-1.39) | <0.001 | 0.166 | 1.49(1.47-1.50) | <0.001 | 0.613 | 1.48(1.46-1.49) | <0.001 | ||
| race | ||||||||||
| white | ref | Ref | ||||||||
| black | 1.12(1.08-1.15) | <0.001 | 0.213 | 1.19(1.15-1.23) | <0.001 | 0.802 | 1.20(1.16-1.24) | <0.001 | ||
| other | 0.76(0.73-0.79) | <0.001 | 0.074 | 0.81(0.77-0.85) | <0.001 | 0.893 | 0.82(0.78-0.86) | <0.001 | ||
| sex | ||||||||||
| male | ref | Ref | ||||||||
| female | 0.97(0.95-0.99) | 0.003 | 0.028 | 0.81(0.80-0.83) | <0.001 | 0.014 | 0.91(0.85-0.97) | 0.002 | 0.97(0.95-0.99) | 0.001 |
| marriage | ||||||||||
| married | ref | ref | ||||||||
| unmarried | 1.50(1.47-1.54) | <0.001 | 0.005 | 1.38(1.34-1.41) | <0.001 | 0.245 | 1.37(1.33-1.40) | <0.001 | ||
| site | ||||||||||
| right | ref | ref | ||||||||
| left | 0.84(0.82-0.86) | <0.001 | <0.001 | 0.93(0.91-0.95) | <0.001 | <0.001 | 0.77(0.72-0.82) | <0.001 | 1.06(1.04-1.08) | <0.001 |
| unknown | 1.25(1.15-1.35) | <0.001 | 0.003 | 1.18(1.09-1.28) | <0.001 | 0.067 | 1.23(1.00-1.51) | 0.049 | 0.98(0.91-1.04) | 0.487 |
| grade | ||||||||||
| I | ref | ref | ||||||||
| II | 1.42(1.36-1.49) | <0.001 | 0.198 | 1.11(1.06-1.16) | <0.001 | 0.136 | 1.12(0.98-1.29) | 0.098 | 1.00(0.96-1.05) | 0.857 |
| III | 2.23(2.13-2.34) | <0.001 | <0.001 | 1.32(1.26-1.39) | <0.001 | <0.001 | 1.96(1.70-2.27) | <0.001 | 0.88(0.84-0.92) | <0.001 |
| IV | 2.38(2.17-2.60) | <0.001 | <0.001 | 1.43(1.31-1.57) | <0.001 | 0.001 | 2.22(1.76-2.79) | <0.001 | 0.86(0.80-0.93) | <0.001 |
| stage | ||||||||||
| I/0 | ref | ref | ||||||||
| II | 1.62(1.56-1.68) | <0.001 | <0.001 | 1.49(1.44-1.55) (1.44-1.55) | <0.001 | <0.001 | 1.61(1.42-1.83) | <0.001 | 0.97(0.94-1.01) | 0.169 |
| III | 2.32(2.24-2.41) | <0.001 | <0.001 | 1.85(1.78-1.93) (1.78-1.93) | <0.001 | <0.001 | 2.14(1.89-2.42) | <0.001 | 0.96(0.92-0.99) | 0.015 |
| IV | 8.29 (7.99-8.61) | <0.001 | <0.001 | 6.86(6.57-7.16) | <0.001 | 0.031 | 5.94(5.26-6.71) | <0.001 | 1.08(1.04-1.12) | <0.001 |
| LNR | ||||||||||
| 0.00≤LNR<0.17 | ref | ref | ||||||||
| 0.17≤LNR<0.41 | 2.11(2.05-2.17) | <0.001 | <0.001 | 1.41(1.36-1.46) | <0.001 | 0.168 | 1.43(1.38-1.48) | <0.001 | ||
| 0.41≤LNR<0.69 | 3.12(3.01-3.23) | <0.001 | <0.001 | 1.90(1.82-1.97) | <0.001 | 0.798 | 1.92(1.85-2.01) | <0.001 | ||
| 0.69≤LNR | 5.23(5.04-5.43) | <0.001 | <0.001 | 2.59(2.48-2.71) | <0.001 | 0.046 | 2.64(2.53-2.77) | |||
Abbreviations: HR, hazard ratio; CI, confidence interval; LNR, lymph node rates.
* Grambsch - Therneau proportional hazards test
a: In univariate analysis, all variables were strongly correlated with all-cause mortality (all p<0.05)
b:we conducted non-proportionality test in univariate analysis with Cox PH model, and we identify that sex, marriage, tumor site, tumor grade, tumor stage, lymph node rates were time-dependent factors (p<0.05). But when we conducted non-proportionality test in multivariate analysis with Cox PH model, we identify that marriage, lymph node rates satisfied the PH assumption (p>0.05).
c:A multivariate analysis with a time-dependent Cox model for all-cause mortality was performed using the following factors: age, race, sex (*log t), marriage, tumor site(*log t), tumor grade(*log t), tumor stage(*log t), lymph node rates.
Figure 2Time-varying effect of each factor on all-cause mortality
A. The HR of unmarried patients was relatively stable over time. D, B. The HR curve of age and race did not exhibit a clearly obvious change with time. C. Using females as a reference, the risk associated with the male gender increased over time. E. The impact of tumor site decreased over time. F. The HR of grade III or IV patients compared with that of grade I patients decreased rapidly within 2 years. G. The HR of stage IV patients compared with that of stage I patients increased with a longer survival time. H. The effects of LNR on all-cause mortality remained constant.
Fine and Gray Proportional Hazards Regression Analysis of colon cancer-specific mortality
| Variable/ Characteristic | HR(95%CI) | P |
|---|---|---|
| age | 1.18(1.17-1.20) | <0.001 |
| race | ||
| white | ref | |
| black | 1.21(1.16-1.26) | <0.001 |
| other | 0.88(0.83-0.93) | <0.001 |
| sex | ||
| male | ref | |
| female | 0.92(0.90-0.95) | <0.001 |
| marriage | ||
| married | ref | |
| unmarried | 1.21(1.17-1.24) | <0.001 |
| site | ||
| right | ref | |
| left | 0.92(0.90-0.95) | <0.001 |
| unknown | 1.14(1.02-1.27) | 0.016 |
| grade | ||
| I | ref | |
| II | 1.14(1.07-1.21) | <0.001 |
| III | 1.44(1.35-1.54) | <0.001 |
| IV | 1.41(1.25-1.60) | <0.001 |
| stage | ||
| I/0 | ref | |
| II | 2.86(2.65-3.07) | <0.001 |
| III | 5.20(4.83-5.59) | <0.001 |
| IV | 21.42(19.90-23.06) | <0.001 |
| LNR | ||
| 0.00≤LNR<0.17 | ref | |
| 0.17≤LNR<0.41 | 1.47(1.41-1.52) | <0.001 |
| 0.41≤LNR<0.69 | 1.93(1.85-2.02) | <0.001 |
| 0.69≤LNR | 2.47(2.34-2.60) | <0.001 |
Abbreviations: HR, hazard ratio; CI, confidence interval; LNR, lymph node rates.
Hazard ratios (95% CIs) were derived from the competing risks model that was controlled for all variables mentioned in the above.
Figure 3Cumulative Incidence Function (CIF) of deaths from colon adenocarcinoma
Figure 4Cumulative Incidence Function (CIF) of deaths from other causes